A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours

Clinical trial NCT01493336 · COMPLETED

Trial details

NCT number: NCT01493336
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer, Colorectal Cancer

Start date: 2012-05-01
Primary completion: 2012-10-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.